Mirum Pharmaceuticals, Inc. (MIRM) /
The profitability of Mirum Pharmaceuticals, Inc. over the past 7 years
Chart Mirum Pharmaceuticals, Inc.: operating income, net income, fiscal 2019–2025 Open the chart →Mirum Pharmaceuticals, Inc. reported a net loss of $23.36M in fiscal 2025, the latest fiscal year on file. That year it had an operating loss of $22.14M. It reported a loss in all 7 years shown.
Year by year
| Fiscal year | Operating income | Net income |
|---|---|---|
| 2025ended Dec 31, 2025 | -$22.14M | -$23.36M |
| 2024ended Dec 31, 2024 | -$87.61M | -$87.94M |
| 2023ended Dec 31, 2023 | -$109.15M | -$163.41M |
| 2022ended Dec 31, 2022 | -$131.22M | -$135.66M |
| 2021ended Dec 31, 2021 | -$173.41M | -$83.99M |
| 2020ended Dec 31, 2020 | -$104.3M | -$103.27M |
| 2019ended Dec 31, 2019 | -$54.74M | -$52.55M |
Fiscal years as Mirum Pharmaceuticals, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Mirum Pharmaceuticals, Inc.
- The revenue of Mirum Pharmaceuticals, Inc.
- The cash flow of Mirum Pharmaceuticals, Inc.
- The debt of Mirum Pharmaceuticals, Inc.
- All of Mirum Pharmaceuticals, Inc.'s financials, charted
Companies of a similar size
- CNOCNO Financial Group, Inc.
- AROCArchrock, Inc.
- BRZEBraze, Inc.
- TENBTENABLE HOLDINGS, INC.
- UNFUNIFIRST CORPORATION
Not investment advice. This page shows what Mirum Pharmaceuticals, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.